Market revenue in 2023 | USD 93.1 million |
Market revenue in 2030 | USD 191.4 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Targeted delivery |
Fastest growing segment | Targeted Delivery |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery |
Key market players worldwide | Merck & Co Inc, Alkermes PLC, Johnson & Johnson, Assertio Holdings Inc, Pfizer Inc, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to controlled release drug delivery market will help companies and investors design strategic landscapes.
Targeted delivery was the largest segment with a revenue share of 25.03% in 2023. Horizon Databook has segmented the Israel controlled release drug delivery market based on wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Israel controlled release drug delivery market , including forecasts for subscribers. This country databook contains high-level insights into Israel controlled release drug delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account